Shifeng Pan

Predicting drug approvals: The Novartis data science and artificial intelligence challenge

Björn Holzhauer, Yingyao Zhou, Simon Wandel, 2021, Patterns.

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Jing Yuan, William R. Sellers, Christoph Lengauer, 2010, Science Translational Medicine.

Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma

Feng Cong, Jeffery A. Porter, Monika Avello, 2013, Proceedings of the National Academy of Sciences.

Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.

Kristine Rose, Christopher Schuster, Hans Skvara, 2011, The Journal of investigative dermatology.

Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors.

Yi Liu, Nathanael Gray, Scott A Lesley, 2005, Bioorganic & medicinal chemistry letters.